To include your compound in the COVID-19 Resource Center, submit it here.

Playing chicken with metastasis

How a chicken embryo screen identified Entos’ metastasis targets

In a June study published in Nature Communications, a University of Alberta team described an in vivo screen that identified genetic drivers of cancer metastasis, and the university has spun out Entos Pharmaceuticals Inc. to develop RNA interference compounds against a selection of those targets.

Screening for genes that contribute to

Read the full 506 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE